Fenretinide-polyvinylalcohol conjugates: New systems allowing fenretinide intravenous administration

Biomacromolecules

Volumn 8, Issue 10, 2007, Pages 3258-3262

  Orienti, I ^a   Zuccari, Guendalina ^a   Bergamante, V ^a   Carosio, R ^b   Gotti, R ^a   Cilli, M ^c   Montaldo, P G ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COVALENT BONDS; DILUTION; DISSOLUTION; DRUG PRODUCTS; HYDROPHILICITY; HYDROPHOBICITY;

BIOAVAILABILITY; FENRETINIDE INTRAVENOUS ADMINISTRATION; FENRETINIDE-POLYVINYLALCOHOL CONJUGATES; VITRO ACTIVITY;

VINYL RESINS;

CARBONIC ACID; FENRETINIDE; MONOMER; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CHEMICAL BOND; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; CELL PROLIFERATION; DIMETHYL SULFOXIDE; DRUG DELIVERY SYSTEMS; FENRETINIDE; HUMANS; INFUSIONS, INTRAVENOUS; MICE; MICE, NUDE; MODELS, CHEMICAL; NEOPLASM METASTASIS; NEUROBLASTOMA; POLYVINYL ALCOHOL; SOLUBILITY;

EID: 35548984440     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm7005592     Document Type: Article

References (19)

1. Lotan, R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy (editorial). J. Natl. Cancer Inst. 1995, 87, 1655-1657.
2. Moon, R. C.; Metha, R. G.; Rao, K. J. Retinoids and Cancer in Experimental Animals. In The Retinoids; Sporn, M. B., Roberts, A. B,, Goodman, D. S., Eds.; Raven Press: New York, 1994; pp 573-595.
3. Niles, R. M. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 2000, 16, 1100-1101.
4. Lo Piccolo, M. S.; Formelli, F.; Lulsch, R.; Ponzoni, M.; Montaldo, P. G.; De Bernardi, B.; Bellini, F. F.; Garaventa, A. Phase I study of fenretinide in neuroblastoma. Am. Assoc. Cancer Res. 2000, PC22: 61.
5. Ponthan, F.; Lindskog, M.; Karnehed, N.; Castro, J.; Kogner, P. Evaluation of anti-tumor effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts. Oncol. Rep. 2003, 10, 1587-1592.
6. Ragazzi, M. B.; Icona, I.; Gervasutti, C.; Lazzarino, M.; Toma, S. Clinical pharmacokinetics of tretinoin. Clin. Pharmacokinet. 1997, 32, 382-402.
7. Adamson, P. C.; Pilot, H. C.; Balis, F. M.; Rubin, J.; Murphy, R. F.; Poplack, D. G. Variability in the oral bioavailability of all-transretinoic acid. J. Natl. Cancer Inst. 1993, 85, 993-996.
8. Reynolds, C. K.; Matthay, K. K.; Villablanca, J. G.; Maurer, B. J. Retinoid therapy of high-risk neuroblastoma. Cancer Lett. 2003, 197, 185-192.
9. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discovery 2004, 2, 347-360.
10. Veronese, F. M.; Morpurgo, M. Bioconjugation in pharmaceutical chemistry. Il Farmaco 1999, 54, 497-516.
11. Maeda, H.; Wu, J.; Sawa, T.; Matsamura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Controlled Release 2000, 65, 271-284.
12. Orienti, I. et al. Self-assembling poly(vinyl alcohol) derivatives, interactions with drugs and control of release. J. Pharm. Sci. 2001, 90, 1435-44.
13. Orienti, I.; Zuccari, G.; Carosio, R.; Fini, A.; Rabesco, A. M.; Montaldo, P. G. Modified doxorubicin for improved encapsulation in PVA polymeric micelles. Drug Delivery 2005, 12, 15-20.
14. Zuccari, G.; Carosio, R.; Fini, A.; Montaldo, P. G.; Orienti, I. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles. J. Controlled Release 2005, 103, 369-380.
15. Orienti, I.; Zuccari, G.; Bergamante, V.; Mileo, E.; Lucarini, M.; Carosio, R.; Montaldo, P. G. Amphiphilic poly(vinyl alcohol) derivatives as complexing agents for fenretinide. Biomacromolecules 2006, 7, 3157-3163.
16. Aresta, M.; Dibenedetto, A.; Fracchiolla, E.; Giannoccaro, P.; Pastore, C.; Papai, I.; Schubert, G. Mechanism of formation of organic carbonates from aliphatic alcohols and carbon dioxide under mild conditions promoted by carbodiimides. DFT calculation and experimental study. J. Org. Chem. 2005, 70, 6177-6186.
17. Binderup, E.; Bjorkling, F.; Hjarnaa, P. V.; Latini, S.; Baltzer, B.; Carlsen, M.; Binderup, L. EB 1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828. Bioorg. Med. Chem. Lett. 2005, 15, 2491-2494.
18. Raffaghello, L.; Pagnan, G.; Pastorino, F et al. In vitro and in vivo antitumor activity of liposomal fenretinide targeted to human neuroblastoma. Int. J. Cancer 2003, 104, 559-567.
19. Orienti, I.; Zuccari, G.; Bergamante, V.; Carosio, R.; Montaldo, P. G. Enhancement of oleyl alcohol anti-tumour activity through complexation in polyvinylalcohol amphiphilic derivatives. Drug Delivery 2007, 14, 209-217.